Disc Medicine shareholder proposes $6.54K stock sale
Disc Medicine, Inc. (IRON) is the issuer in a Rule 144 notice from Atlas Venture Fund XII, identified as a shareholder, proposing the sale of 115 common shares through Merrill Lynch.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Disc Medicine, Inc. (IRON) is the issuer in a Rule 144 notice from Atlas Venture Fund XII, identified as a shareholder, proposing the sale of 115 common shares through Merrill Lynch. The notice lists October 19, 2026 as the approximate sale date and an aggregate market value of $6,536.6. Atlas Venture Fund XII acquired the shares from the issuer in a private placement on May 1, 2020, with cash payment. Ommer Chohan signed the notice.
Key Figures
Key Terms
Rule 144 regulatory
Private Placement financial
Common Stock technical
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.